GGrantIndex
← Search

STABLE MIXED CHIMERISM AND TOLERANCE OF VASCULARIZED COMPOSITE ALLOGRAFTS VIA BCL-2 INHIBITION

$46,569FY2022Department of the ArmyDOD

The General Hospital Corporation

Investigators

View source on USAspending →
STABLE MIXED CHIMERISM AND TOLERANCE OF VASCULARIZED COMPOSITE ALLOGRAFTS VIA BCL-2 INHIBITION · GrantIndex